Co-careldopa (Carbidopa/levodopa) Prescribing at THE WILLOW GROUP
Drugs used in parkinsonism and related disorders | Central Nervous System
Items (12m)
1,497
Total Quantity
133.9K
NHS Cost
£11.4K
vs National Avg
+562.4%
THE WILLOW GROUP prescribed 1,497 items of Co-careldopa (Carbidopa/levodopa) over the last 12 months at a cost of £11,367 to the NHS. This is 562.4% above the national average prescribing rate. Co-careldopa (Carbidopa/levodopa) is classified under Drugs used in parkinsonism and related disorders in the BNF.
Monthly Prescribing Trend
Jul 2026
123
Jul 2026
109
Jul 2026
163
Jul 2026
131
Jul 2026
132
Jul 2026
143
Jul 2026
110
Jul 2026
111
Jul 2026
125
Jul 2026
94
Jul 2026
120
Jul 2026
136
Prescribing Details
| Total Items | 1,497 |
|---|---|
| Total Quantity | 133,888 |
| Total NHS Cost | £11,367 |
| Presentations | 9 different forms |
| vs National Average | +562.4% |
Co-careldopa (Carbidopa/levodopa) Prescribing Comparison
| This practice | 1,497 items |
|---|---|
| National average per practice | 226 items |
| Difference | +562.4% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.